• 

  Narina K. Sargsyants

  Infectious Disease Specialist, Hepatologist

  Narina K. Sargsyants

  • Speciality
    Infectious Disease Specialist, Hepatologist
  • Degrees
    MD, PhD
  • Phone
    +374-91-57-98-45

  Education

  1990-1996 Yerevan State Medical University, Faculty of General Medicine

  1996-1999 Yerevan State Medical University, Residency, speciality – Infectious diseases

  2004-2009 Yerevan State Medical University, PhD research, topic: “Clinical, epidemiological peculiarities and results of treatment with Pegylated interferon-alpha 2a and Ribavirin of chronic viral hepatitis C in Armenia”

  Trainings

  2014 Department of Gastroenterology/Hepatology at the Medical University – General hospital Vienna (AKH), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research, March 3 – 28, (Supervisor - Prof Peter Ferenci)

  2014 Department of Division of Gastroenterology, Hepatology, Nephrology and Diabetology at the Medical University Hospital – Salzburger Landeskliniken (SALK), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research, April 1 – 25, (Supervisor - Dr Michael Strasser)

  2011 Università Cattolica, Rome, Italy, sponsored by European Society of Clinical Microbiology and Infectious Diseases (ESCMID), October 27 th to November 4th, (Supervisor - Prof Roberto Cauda)

  2010 Department of Infectious Diseases and tropical medicine at the Medical University - General hospital Vienna (AKH), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research from September 7 –30, (Supervisor - Prof Wolfgang Graninger)

  2010 Hospital Universitario Virgen Macarena, Sevilla, Spain, sponsored by European Society of Clinical Microbiology and Infectious Diseases (ESCMID), April 21th to April 30th, (Supervisor - Prof Jesús Rodríguez-Baño)

  2008 MEDICAL EXCHANGE PROGRAMME FOR YOUNG HIV PHYSICIANS in CHU de Bicêtre, Paris, sponsored by European AIDS Clinical Society (EACS), July 15 th to August 25th (Supervisor - Prof Jean François Delfraissy)

  Professional activity

  since 2024 Infectologist, Hepatologist, Head of clinical service, "EUROLAB", Yerevan,

  since 2022 Head of the Department of Infectious Diseases, National Institute of Health

  since 2021 WHO focal point on Viral Hepatitis

  since 2021 President of the Armenian Association of Infectious Diseases

  2020-2023 Chairman of the ethics committee, "National Center of Infectious Diseases of the RA Ministry of Health" Armenia

  2020-2023 Deputy Director (Development, Science), National Centre of Infectious Diseases

  2020-2022 Head of Department of Infectious Diseases and Epidemiology, National Institute of HealthNational Institute of Health"

  2020-2022 Global Fund Projects Coordinator in NCID, Armenia

  since 2020 Scientific council Member, National Institute of Health

  2019-2020 Assistant Professor: Department of Epidemiology, Microbiology and Infectious Diseases, "National Institute of Health"

  since 2018 Infectologist, hepatologist in Elit-Med Medical Center

  since 2018 Ministry of Health, Consultant in the field of Infectious Diseases

  2016-2019 Hepatologist in Medecins sans frontiers (MSF) France in Armenia “HCV treatment with DAA among MDR-TB patients”

  2007-2019 Infectologist, Department of Infectious Diseases, Armenicum Clinical Center

  2007-2009 Head of the Department of Infectious Diseases, Yerevan State Medical University named after Mkhitar Heratsi

  2007-2009 Scientific council Member, Yerevan State Medical Universit

  2007-2009 Member of material and methods examination commission, Yerevan State Medical University

  2004-2009 PhD research, topic – “Clinical, epidemiological peculiarities and results of treatment with Pegylated interferon-alpha 2a and Ribavirin of chronic viral hepatitis C in Armenia”, Yerevan State Medical University

  1999-2007 Assistant Professor, Department of Infectious Diseases, Yerevan State Medical University

  1998-2020 Infectologist in Nor-Arabkir Medical Center

  Publications

  177 (85 in English), include 23 in Russian and 104 in international publications, 60 abstracts and/or posters in international conference

  EDITORIAL BOARD: «World Journal of Hepatology»

  2023 Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study, The Lancet Gastroenterology & Hepatology, July 2023, DOI:https://doi.org/10.1016/S2468-1253(23)00197-8

  2023 CURRENT ACHIEVEMENTS AND CHALLENGES IN VIRAL HEPATITIS B AND C ELIMINATION PROGRAM IN THE REPUBLIC OF ARMENIA, Global Hepatitis Summit 2023, P136, Paris, April 25-28

  2023 Prevalence of anti-HBc seropositivity among checked patients in Armenia, 15th Paris Hepatology Conference, P 00009, 27-29 March, DOI:10.13140/RG.2.2.25810.43201

  2023 CONNECTION OF HIV INFECTION EPIDEMICS IN THE REPUBLIC OF ARMENIA AND THE RUSSIAN FEDERATION, Epidemiol. infectious diseases. Current. question 2023; 13(3): 27–34, DOI:10.18565/epidem.2023.13.3.27–34

  2023 The role of socio-demographic factors in the preference of behavioral strategies when seeking medical help in patients infected with HIV, Epidemiol. infectious diseases. Current. question 2023; 13(3): 35–42, DOI: https://dx.doi.org/10.18565/epidem.2023.13.3.35-42

  2023 The necessity of antimicrobial stewardship program implementation and monitoring in Armenia, Armenian Journal of Health and Medical Sciences, 0231, p 66-67

  2023 Changes in antiretroviral treatment approaches in the Republic of Armenia, Armenian Journal of Health and Medical Sciences, 0307, p. 67

  2023 Features of the course and treatment of patients with coinfection TB/HIV and chronic hepatitis B and C, Armenian Journal of Health and Medical Sciences, p78-79

  2023 ANALYSIS OF CASES OF VIROLOGICAL INEFFICIENCY OF ANTIRETROVIRAL THERAPY FOR HIV INFECTION AMONG RESIDENTS OF THE REPUBLIC OF ARMENIA, Molecular Diagnosticsand Biological Safety-2023, Сongress with international participation, Moscow, April, 27–28, p 208-209

  2022 Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? Frontiers in Pharmacology13:1062408, November. DOI: 10.3389/fphar.2022.1062408

  2022 SITUATION WITH COVID-19 AMONG HIV-INFECTED PATIENTS IN ARMENIA, 20th Edition of the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, Paris, 8 Jun - 10 Jun, Poster 33, DOI: 10.13140/RG.2.2.14485.81122

  2022 IMPLEMENTATION OF HCV-INFECTION TREATMENT PROGRAMM WITH DAA IN ARMENIA AMONG HIV-INFECTED PATIENTS IN COVID-19 ERA, 20th Edition of the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, Paris, 8 Jun - 10 Jun, Poster 24, DOI:10.13140/RG.2.2.15691.67362

  2022 Monkeypox A neglected infection becomes re-emerging global challenge. Armenian Journal of Health & Medical Sciences (AJHMS), September 2022 p.8-12, DOI: 10.54235/27382737-2022.v2.1-8

  2022 Prevalence and risk factors of hepatitis C virus infection in Armenia, 2021, The European Journal of Public Health 32 (Supplement_3), October 2022 DOI: 10.1093/eurpub/ckac131.392

  2022 Peculiarities of HIV infection in children in the Republic of Armenia. EECA INTERACT 2022 was held in Riga, Latvia, December 13-14, abstract 20, p.24-25

  2022 Analyses of situation and implementation of new approach to PrEP in HIV-infected patients in Armenia. EECA INTERACT 2022 was held in Riga, Latvia, December 13-14, abstract 45, p.43-44 DOI: 10.13140/RG.2.2.14485.81122

  2022 Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey. Viruses 14(11):2320, October 2022 DOI: 10.3390/v14112320

  2022 Integrating hepatitis C treatment into multidrug-resistant TB care, Public Health Action 12(2):96-101m June 2022 DOI: 10.5588/pha.22.0002

  Scientific works

  2021 Concomitant treatment of chronic hepatitis C with direct acting antivirals and multidrug-resistant tuberculosis is effective and safe, Open Forum Infectious Diseases, January 2021, DOI: 10.1093/ofid/ofaa653

  2021 Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D, Endocrine 71(20). January 2021, DOI: 10.1007/s12020-020-02597-7

  2020 Lipids profile, gamma-glutamyl transferase and hyperferritinemia in patients with NAFLD/NASH, 29th APASL Conference 2020, 4th-8th March, Bali, Nusa Dua

  2020 PIVKA-II additional marker for HCC detection in HCV-infected patients after SVR in resource-limited setting, 29th APASL Conference 2020, 4th-8th March, Bali, Nusa Dua

  2020 Vitamin D deficiency in patients with chronic liver diseases, 29th APASL Conference 2020, 4th-8th March, Bali, Nusa Dua

  2020 Unusual combined case of liver cirrhosis due to HBV-infection and Budd-Chiari syndrome, 29th APASL Conference 2020, 4th-8th March, Bali, Nusa Dua

  2020 Unusual case of severe herbs-induced systemic manifestations, 29th APASL Conference 2020, 4th-8th March, Bali, Nusa Dua

  2019 HCC development in HCV-infected patients and diagnosis challenges in resource-limited settings, Poster Presentation №21, 17th International Workshop on Co-infection: HIV & Hepatitis, 22 - 24 May, Rome, Italy

  2019 Influence of direct antiviral agents on fibrosis degree and outcome in patients with chronic hepatitis C, XXV Russian congress HEPATOLOGY TODAY, October 7-9, Moscow5

  2019 Peculiarities of natural course of chronic hepatitis B, XXV Russian congress HEPATOLOGY TODAY, October 7-9, Moscow

  2018 Hepatitis C and multidrug resistant tuberculosis co-morbidities: no longer an untreatable combination, Poster Presentation at Médecins Sans Frontières (MSF) Scientific Day, May 15, 2018, https://doi.org/10.7490/f1000research.1115465.1

  2018 HYPERFERRITINEMIA IN PATIENTS WITH CHRONIC LIVER DISEASES, Poster Presentation (CC-04-099) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India

  2018 DYNAMIC OF CLINICAL AND LABORATORY ABNORMALITIES IN SMALL COHORT OF HCV-INFECTED PATIENTS TREATED WITH SOFOSBUVIR CONTAIN REGIMENS, Poster Presentation (CC-04-059) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India

  2018 CLINICAL AND VIROLOGICAL RESPONSE ON INDIAN GENERIC OF DAA REGIMENS WITH/WITHOUT IFN IN HCV-INFECTED PATIENTS, REAL WORLD DATA, Poster Presentation (CC-04-058) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India

  2018 BIOCHEMICAL PARAMETERS ABNORMALITIES IN EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS, Poster Presentation (CC-01-051) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India

  2018 Description of the Course and Outcomes of Antiviral Treatment of 1000 HCV Infected Patients, Poster Presentation, abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India

  2017 Real world data concerning rapid virological response and tolerability of DAAs with/without IFN regimens in small cohort of HCV-infected patients, 13th International Workshop on Co-infection: HIV & Hepatitis, on 21 - 23 June, Lisbon, Portugal

  2017 Nosocomial outbreak of HCV-infection, Poster Presentation (PP1878) abstract SA-APASL2017-25497 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February

  2017 Result of short questionary concerning guidelines on management of HBV-infection among Armenian physicians, Poster Presentation (PP0791) abstract SA-APASL2017-25577 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February

  2017 Outcomes of Severe Complications in Patient with Decompensated HCV-associated Cirrhosis with SVR after Treatment with Sofosbuvir/Ledipasvir, Poster Presentation (PP1893) abstract SA-APASL2017-27938 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February

  2016 Success in difficult-to-treat patient with НСV-associated glomerulonephritis, Poster Presentation abstract 10110 at the 25th Conference of the APASL, Tokyo, Japan, February 20-24

  2015 Influence of predictor variables on FibroMax results, Abstract/ePoster RS-2771 at the European Association for the Study of the Liver the 50th International Liver Congress (ILC), Vienna, Austria, April 22- 26, Hepatology, Vol.62, S 736-737

  2015 Prognostic value of hyperferritinemia in patients with chronic hepatitis C, Poster Presentation POS-C4 at APASL STC on HCV, 18-20 December, New Delhi, India, Poster of Distinction

  2015 Comparison of HCV genotyping distribution in Armenia during ten years, Abstract, Poster Presentation at the 22nd International Symposium on Hepatitis C Virus and Related Viruses meeting, Strasbourg, France, October 9-13

  2014 Influence of predictor variables on degree of fibrosis in chronic НВV-infection measured by Fibrotest, Poster P73, EASL/APASL Special Conference on the Optimal Management of Hepatitis B Virus Infection in Athens, September 25-27

  2013 INFLUENCE OF PREDICTOR VARIABLES ON QUALITY OF LIFE PATIENTS WITH CHRONIC VIRAL HEPATITIS C, Poster Presentation abstract A-533-0021-00223 at the 48th annual meeting of the European Association for the Study of the Liver, The Netherlands, April 24-28

  2013 The experience of granulocyte colonystimulating factor administration for neutropenia correction in IFN-experienced patient with HCV-associated liver cirrhosis treated with Peg-IFN alpha 2a plus Ribavirin, Poster Presentation abstract A-535-0018-02382 at the 23rd Conference of the APASL, Singapore, 6-10 June

  2013 Gammaglutamyltransferase in patient with chronic hepatitis C during the treatment with PEG Interferon Alfa 2a with ribavirin, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7

  2013 Results of IL-28B gene polymorphism in patients with chronic НCV-infection in Armenia, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7

  2013 Some results of GenoFibroTest in patients with chronic НСV-infection, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7

  2012 Immunoglobulins concentration in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection, International Symposium on HIV & Emerging Infectious Diseases, France, Marseille, 23-25 May Abstract-No:1215

  2012 Predictor variables of efficacy the treatment with PEG Interferon Alfa 2a plus ribavirin in chronic hepatitis C, 14th International Symposium on Viral Hepatitis and liver Disease (ISVHLD), China, Shanghai 22-25 June

  2011 Interrelationship of immune surrogate markers in HIV-infected patients, The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome 17-20 July, abstract CD-ROM, Abstract-No: A-361-0035-03722

  2011 Immune surrogate markers in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection, The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome 17-20 July, abstract CD-ROM, Abstract-No: A-361-0034-03805

  2011 Biphasic thyroid dysfunction in patient with chronic hepatitis C treated with interferon-alpha and ribavirin, Poster Presentation abstract A-315-0024-01825 at the 21th Conference of the APASL, 17-20 February 2011, QSNCC, Bangkok Thailand

  2011 Analysis of ferritinemia level in patients with chronic hepatitis C, 17th Russian Gastroenterology Weak, oral presentation

  2010 Severe case of pneumocystis pneumonia in HIV-patient due to IRIS, Poster Presentation at 25th IUSTI Europe Conference

  2010 Clinical aspects of chronic HCV-infection in Armenia, Poster Presentation at The 3rd International Tehran Hepatitis Congress

  2010 Epidemiology of viral hepatitis C in Armenia, Poster Presentation at The 3rd International Tehran Hepatitis Congress

  2010 Influence of predictor variables on side effects of the treatment with PEG interferon Alfa 2a plus ribavirin in chronic hepatitis C, Poster Presentation No.: P-144 at 4th Ditan International Conference on Infectious Diseases (DICID), International Journal of Infectious Diseases Abstract No. SA00360 (Prize Winner)

  2010 Comparison of liver function tests in responders and non-responders of the treatment with PEG Interferon Alfa 2a plus ribavirin in chronic hepatitis C, Poster Presentation No.: PP-324 at the 20th Conference of the APASL, 25 – 28 March, Beijing, China

  2008 Soluble Markers of Immune Activation in HIV/HCV Co-infection, 15th International Symposium on HIV & Emerging Infectious Diseases, France, Toulon, p. 2

  2004-2009 Candidate thesis "Clinico-epidemiological and therapeutic features of chronic viral hepatitis C in Armenia"

  Awards

  1998 Award of the Ministry of Health for active participation in medical work during the outbreak of cholera in Armenia

  2014 World Leading Specialist Award, International Center for Biography, Cambridge, England

  2014 Woman of the Year Award 2014, International Center for Biography, Cambridge, England

  2014 Distinguished Intellectuals of the 21st Century Award, International Center for Biography, Cambridge, England

  2015 TOP 100 Health Professionals Award, Center for International Biography, Cambridge, England

  2020 Commemorative medal of the Ministry of Health of the Republic of Armenia for selfless service and responsible work in the fight against the new coronavirus disease and in the emergency situation of the health system

  2021 Mkhitar Heratsi medal, from the Decree of the President of the Republic of Armenia NH-63-A, for the contribution made in the organization and implementation of the prevention, control and treatment of the coronavirus epidemic in the Republic of Armenia

Meet and Greet our Team Members

• 

  Hayk D. Yenokyan

  Surgeon (plastic), Surgeon (maxillofacial)

  Head of Plastic and Maxillofacial Surgery Service
• 

  Ashot V. Zargaryan

  Surgeon (plastic)

  Head of Plastic Surgery service at “Elit-Med” Medical Center
• 

  Roza S. Khachatryan

  Gynecologist

  Obstetrician-gynecologist
• 

  Karen R. Kasparyan

  Otorhinolaryngologist

  Otorhinolaryngologist
• 

  Narina K. Sargsyants

  Infectious Disease Specialist, Hepatologist

  Infectologist, Hepatologist